Budget impact of phentermine and topiramate extended-release (PHEN/TPM ER) in overweight and obese patients with comorbid prediabetes or type 2 diabetes mellitus (T2DM)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1415
https://www.valueinhealthjournal.com/article/S1098-3015(14)01466-1/fulltext
Title :
Budget impact of phentermine and topiramate extended-release (PHEN/TPM ER) in overweight and obese patients with comorbid prediabetes or type 2 diabetes mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01466-1&doi=10.1016/j.jval.2014.03.1415
First page :
A242
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
885